Appian Way Asset Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-922,656
Closed -$14.6M 4
2025
Q3
$14.6M Sell
922,656
-2,890,685
-76% -$41.9M 2.62% 12
2025
Q2
$43.7M Buy
3,813,341
+1,342,053
+54% +$15.1M 9.66% 4
2025
Q1
$33.4M Sell
2,471,288
-60,988
-2% -$1.01M 7.49% 6
2024
Q4
$42.8M Buy
2,532,276
+851,603
+51% +$16.6M 8.91% 5
2024
Q3
$34.2M Buy
+1,680,673
New +$34.4M 7.68% 5
2024
Q2
Sell
-288,462
Closed -$7.58M 43
2024
Q1
$7.58M Buy
+288,462
New +$8.22M 1.99% 17
2022
Q4
Sell
-768,907
Closed -$19M 30
2022
Q3
$19M Buy
768,907
+623,307
+428% +$20.6M 8.3% 6
2022
Q2
$4.66M Buy
+145,600
New +$5.36M 1.9% 18

Other funds holding CC

Appian Way Asset Management's CC Position: Q4 2025 in Review

Appian Way Asset Management sold out of Chemours (CC) in Q4 2025, closing a stake of 922,656 shares — an estimated $14.6M sold.

Appian Way Asset Management first reported a position in CC in Q2 2022 and held it in 8 quarters. The position peaked at $43.7M in Q2 2025. 435 funds tracked by Wall St. Rank hold CC as of Q4 2025.

  • Appian Way Asset Management reported no remaining Chemours position as of Q4 2025 after selling out during the quarter.
  • Appian Way Asset Management sold 922,656 Chemours shares in Q4 2025, an estimated $14.6M.
  • Appian Way Asset Management first reported a position in Chemours in Q2 2022 and held it in 8 quarters.
  • Appian Way Asset Management's Chemours position peaked at $43.7M in Q2 2025.
  • 435 funds tracked by Wall St. Rank held Chemours as of Q4 2025.

Based on Appian Way Asset Management's 13F filing for Q4 2025.